Cargando…

High-dose intravenous immunoglobulin therapy for novel coronavirus disease 2019: a brief report of two cases

Detalles Bibliográficos
Autores principales: Erdogan, Cem, Ciftci, Bahadir, Kizilaslan, Deniz, Ekinci, Mursel, İptec, Gülsen, Gemici, Ali İhsan, Karaaslan, Pelin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481541/
http://dx.doi.org/10.1186/s42077-020-00089-4
_version_ 1783580626441469952
author Erdogan, Cem
Ciftci, Bahadir
Kizilaslan, Deniz
Ekinci, Mursel
İptec, Gülsen
Gemici, Ali İhsan
Karaaslan, Pelin
author_facet Erdogan, Cem
Ciftci, Bahadir
Kizilaslan, Deniz
Ekinci, Mursel
İptec, Gülsen
Gemici, Ali İhsan
Karaaslan, Pelin
author_sort Erdogan, Cem
collection PubMed
description
format Online
Article
Text
id pubmed-7481541
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-74815412020-09-10 High-dose intravenous immunoglobulin therapy for novel coronavirus disease 2019: a brief report of two cases Erdogan, Cem Ciftci, Bahadir Kizilaslan, Deniz Ekinci, Mursel İptec, Gülsen Gemici, Ali İhsan Karaaslan, Pelin Ain-Shams J Anesthesiol Letter to the Editor Springer Berlin Heidelberg 2020-09-10 2020 /pmc/articles/PMC7481541/ http://dx.doi.org/10.1186/s42077-020-00089-4 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter to the Editor
Erdogan, Cem
Ciftci, Bahadir
Kizilaslan, Deniz
Ekinci, Mursel
İptec, Gülsen
Gemici, Ali İhsan
Karaaslan, Pelin
High-dose intravenous immunoglobulin therapy for novel coronavirus disease 2019: a brief report of two cases
title High-dose intravenous immunoglobulin therapy for novel coronavirus disease 2019: a brief report of two cases
title_full High-dose intravenous immunoglobulin therapy for novel coronavirus disease 2019: a brief report of two cases
title_fullStr High-dose intravenous immunoglobulin therapy for novel coronavirus disease 2019: a brief report of two cases
title_full_unstemmed High-dose intravenous immunoglobulin therapy for novel coronavirus disease 2019: a brief report of two cases
title_short High-dose intravenous immunoglobulin therapy for novel coronavirus disease 2019: a brief report of two cases
title_sort high-dose intravenous immunoglobulin therapy for novel coronavirus disease 2019: a brief report of two cases
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481541/
http://dx.doi.org/10.1186/s42077-020-00089-4
work_keys_str_mv AT erdogancem highdoseintravenousimmunoglobulintherapyfornovelcoronavirusdisease2019abriefreportoftwocases
AT ciftcibahadir highdoseintravenousimmunoglobulintherapyfornovelcoronavirusdisease2019abriefreportoftwocases
AT kizilaslandeniz highdoseintravenousimmunoglobulintherapyfornovelcoronavirusdisease2019abriefreportoftwocases
AT ekincimursel highdoseintravenousimmunoglobulintherapyfornovelcoronavirusdisease2019abriefreportoftwocases
AT iptecgulsen highdoseintravenousimmunoglobulintherapyfornovelcoronavirusdisease2019abriefreportoftwocases
AT gemicialiihsan highdoseintravenousimmunoglobulintherapyfornovelcoronavirusdisease2019abriefreportoftwocases
AT karaaslanpelin highdoseintravenousimmunoglobulintherapyfornovelcoronavirusdisease2019abriefreportoftwocases